Herantis Pharma Oyj (HRTIS) — Cash Flow Quality Index
Herantis Pharma Oyj (HRTIS) has a Cash Flow Quality Index of -1.41x as of December 2023. Operating cash flow of €-2.92 Million is below net income of €2.08 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Herantis Pharma Oyj to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Herantis Pharma Oyj Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Herantis Pharma Oyj across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see HRTIS cash flow conversion.
Annual Cash Flow Quality Index for Herantis Pharma Oyj (2023–2023)
Year-by-year earnings quality comparison for Herantis Pharma Oyj.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -16.57x | €-4.64 Million | €279.84K | — |